Acetaldehyde Aconitum Napellus Whole Arnica Montan

證據等級: L5

預測適應症: 0 個

Multi-Component Homeopathic Preparation (25 Ingredients): Insufficient Data for Repurposing Evaluation

One-Sentence Summary

This submission contains a complex 25-ingredient preparation comprising classical homeopathic substances including botanicals, minerals, and biological derivatives (e.g., Arnica Montana, Arsenicum, Phosphorus, Lachesis Muta Venom). No TxGNN-predicted new indications were generated for this entry, and no regulatory approvals or mapped original indications were found. As a result, this candidate cannot be evaluated under the standard drug repurposing framework at this time.

Quick Overview

Item	Content
Original Indication	None on record
Predicted New Indication	None — TxGNN returned no predictions
TxGNN Prediction Score	N/A
Evidence Level	N/A — No predictions, no supporting studies identified
Market Status	Not marketed (0 approvals)
Number of NDAs	0
Recommended Decision	Hold

Why No Prediction Was Generated

This preparation consists of 25 separate active ingredients spanning botanical extracts, elemental substances, and venom-derived homeopathic dilutions. The TxGNN model operates on individual DrugBank-mapped molecules; because no DrugBank ID could be assigned to this multi-component preparation as a unit, the pipeline was unable to generate a drug–disease prediction score.

The composition pattern — including Aconitum Napellus, Arnica Montana, Baptisia Tinctoria, Eupatorium Perfoliatum, Echinacea Angustifolia, Gelsemium Sempervirens, and Phosphorus — is characteristic of a classical homeopathic flu/immune-response complex. However, without a unified pharmacological profile or INN-level DrugBank mapping, the knowledge-graph and deep-learning prediction steps cannot be applied.

Additionally, neither the mechanism of action (MOA) nor any original approved indication was provided, leaving the mechanistic plausibility analysis with no starting point.

Clinical Trial Evidence

Currently no related clinical trials registered.

Literature Evidence

Currently no related literature available.

Market Information

No regulatory approvals on record (0 licenses). This preparation is not currently marketed.

Safety Considerations

Please refer to the package insert for safety information.

Note on specific ingredients: Several components in this formulation carry known toxicological concerns at non-homeopathic doses — including Arsenic Trioxide, Mercuric Chloride, Aconitum Napellus alkaloids, and Formaldehyde. If any future clinical evaluation is considered, a comprehensive safety dossier covering each ingredient individually will be required.

Conclusion and Next Steps

Decision: Hold

Rationale: This candidate could not be processed through the TxGNN repurposing pipeline due to the absence of a DrugBank ID, no approved original indication, and no mapped pharmacological target. Without a prediction score or supporting evidence, there is no basis for a repurposing recommendation.

To proceed, the following is needed:

DrugBank mapping: Identify whether any individual active ingredients (e.g., Cortisone Acetate, Dopamine Hydrochloride, Arsenic Trioxide) can be evaluated independently as repurposing candidates with their own DrugBank IDs.
Preparation identity clarification: Confirm whether this is a known commercial homeopathic product (e.g., a branded multi-symptom flu remedy) with a published indication and monograph.
MOA documentation: Provide mechanism-of-action data for any individual component intended for further evaluation.
Safety dossier: Compile ingredient-level warnings, contraindications, and interaction data — especially for the high-toxicity components listed above.
Re-submission as single-ingredient candidates: If individual components (e.g., Arsenic Trioxide, Cortisone Acetate, Dopamine Hydrochloride) are the actual targets of interest, each should be submitted as a separate Evidence Pack for independent evaluation.
Disclaimer

This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.